The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-0169-2027·Announced 2026-11-11

Fresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns

Fresenius Medical Care is recalling specific lots of DELFLEX peritoneal dialysis solution because of potential leaks in the bag print area that may compromise sterility.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which indicates a situation where use of the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. The source does not report any illnesses, injuries, or deaths.

Plain-English summary

Fresenius Medical Care Renal Therapies Group, LLC is recalling 1,065 cases of DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/Low Calcium. The affected product is a 2,500 mL single-dose bag, sterile and non-pyrogenic, intended for intraperitoneal use. The recall covers two specific lots: 25HGPD037 (expiring 12/31/2026) and 26CGPD074 (expiring 9/30/2027).

The recall was initiated because complaints were received regarding potential leaks from small perforations in the print area of the primary bag. These defects raise concerns about the assurance of sterility for the dialysis solution. The affected product was distributed nationwide in the USA.

Patients and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If the product is found, it should be removed from use and returned to the distributor or manufacturer according to standard recall procedures.

The recalled product

Product
DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)
Brand
DELFLEX

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot#: 25HGPD037
  • Exp 12/31/2026
  • 26CGPD074
  • Exp 9/30/2027.

Distribution

Distributed nationwide across the United States.

Same manufacturer · Fresenius Medical Care Renal Therapies Group, LLC

See all →

Similar recalls